{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T04:21:34Z","timestamp":1667017294518},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,9,15]]},"DOI":"10.2169\/internalmedicine.4524-20","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T22:04:42Z","timestamp":1592172282000},"page":"2275-2280","source":"Crossref","is-referenced-by-count":0,"title":["A Patient with Cardiac Sarcoidosis in Whom an Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxyglucose and Sustained Ventricular Tachycardia Recurred 3.5 Years after Discontinuing Oral Corticosteroid Therapy"],"prefix":"10.2169","volume":"59","author":[{"given":"Shuichi","family":"Fujita","sequence":"first","affiliation":[{"name":"Department of Cardiology, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical College, Japan"},{"name":"Medical Education Center, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Miyamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fujiyoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoshige","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Hoshiga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical College, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. The Japanese Circulation Society (JCS). Guidelines for diagnosis and treatment of cardiac sarcoidosis (JCS 2016) (Chair: Fumio Terasaki) [Internet]. [cited 2017 Feb 24]. Available from: http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2016_terasaki_h.pdf (in Japanese)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Terasaki F, Azuma A, Anzai T, et al.; Japanese Circulation Society Joint Working Group. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version. Circ J 83: 2329-2388, 2019.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","volume":"9","author":"BP Betensky","year":"2012","unstructured":"3. Betensky BP, Tschabrunn CM, Zado ES, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 9: 884-891, 2012.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","volume":"15","author":"J Kron","year":"2013","unstructured":"4. Kron J, Sauer W, Schuller J, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 15: 347-354, 2013.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schuller JL, Zipse M, Crawford T, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 23: 925-929, 2012.","DOI":"10.1111\/j.1540-8167.2012.02350.x"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Epstein AE, DiMarco JP, Ellenbogen KA, et al. American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, Heart Rhythm Society. 2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 127: e283-e352, 2013.","DOI":"10.1161\/CIR.0b013e318276ce9b"},{"key":"7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.hrthm.2008.04.015","volume":"5","author":"AE Epstein","year":"2008","unstructured":"7. Epstein AE, Dimarco JP, Ellenbogen KA, et al. American College of Cardiology\/American Heart Association Task Force on Practice, American Association for Thoracic Surgery, Society of Thoracic Surgeons. ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm 5: 934-955, 2008.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"8. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11: 1305-1323, 2014.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac sarcoidosis. J Am Coll Cardiol 68: 411-421, 2016.","DOI":"10.1016\/j.jacc.2016.03.605"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nagai T, Nagano N, Sugano Y, et al. Effect of discontinuation of prednisolone therapy on risk of cardiac mortality associated with worsening left ventricular dysfunction in cardiac sarcoidosis. Am J Cardiol 117: 966-971, 2016.","DOI":"10.1016\/j.amjcard.2015.12.033"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Terasaki F, Kuwabara H, Takeda Y, et al. Clinical feature and histopathology of cardiac sarcoidosis with refractory heart failure-an autopsy case. Intern Med 58: 3551-3555, 2019.","DOI":"10.2169\/internalmedicine.3147-19"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Terasaki F, Yoshinaga K. New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol 3: 42-45, 2017.","DOI":"10.17996\/anc.17-00042"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kiko T, Yoshihisa A, Kanno Y, et al. A multiple biomarker approach in patients with cardiac sarcoidosis. Int Heart J 59: 996-1001, 2018.","DOI":"10.1536\/ihj.17-695"},{"key":"14","unstructured":"14. Isobe M, Tezuka D. Isolated cardiac sarcoidosis: clinical characteristics, diagnosis and treatment. Int J Cardiol 182: 132-140, 2015."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Terasaki F, Fujita SI, Kanzaki Y, Hirose Y, Ishizaka N. Spontaneous reduction in abnormal myocardial uptake of fluorine-18 fluorodeoxygluose in a patient with cardiac sarcoidosis. Int Heart J 59: 647-651, 2018.","DOI":"10.1536\/ihj.17-315"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/18\/59_4524-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T12:55:07Z","timestamp":1666961707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/18\/59_4524-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":15,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4524-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}